LABU Holdings Information

LABU is an equity ETF with a total of 144 individual holdings. The top holdings are S&P Biotechnology Select Industry Index Swap stock at 30.04%, Dreyfus Govt Cash Man Ins at 12.72%, Goldman Sachs Sterling FixInc Port at 11.09%, Goldman Sachs Fin Gov 465 Institut at 10.75%, and CRISPR Therapeutics AG at 1.34%.

Total Holdings

144

Top 10 Percentage

72.03%

Asset Class

Equity

ETF Category

Trading--Leveraged Equity

Assets

698.66M

PE Ratio

n/a

Sector Allocation

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	n/a	S&P Biotechnology Select Industry Index Swap	30.04%	210,424
2	n/a	Dreyfus Govt Cash Man Ins	12.72%	92,623,839
3	n/a	Goldman Sachs Sterling FixInc Port Inc	11.09%	80,783,027
4	n/a	Goldman Sachs Fin Gov 465 Institut	10.75%	78,271,150
5	CRSP	CRISPR Therapeutics AG	1.34%	160,510
6	UTHR	United Therapeutics Corporation	1.26%	21,119
7	MRNA	Moderna, Inc.	1.22%	344,453
8	EXEL	Exelixis, Inc.	1.21%	222,113
9	ABBV	AbbVie Inc.	1.21%	39,566
10	NBIX	Neurocrine Biosciences, Inc.	1.19%	59,283
11	MDGL	Madrigal Pharmaceuticals, Inc.	1.19%	19,469
12	AMGN	Amgen Inc.	1.18%	30,066
13	HALO	Halozyme Therapeutics, Inc.	1.18%	110,470
14	REGN	Regeneron Pharmaceuticals, Inc.	1.17%	15,065
15	NTRA	Natera, Inc.	1.17%	49,318
16	INSM	Insmed Incorporated	1.15%	57,381
17	GILD	Gilead Sciences, Inc.	1.14%	72,656
18	RVMD	Revolution Medicines, Inc.	1.14%	187,076
19	INCY	Incyte Corporation	1.13%	97,086
20	BMRN	BioMarin Pharmaceutical Inc.	1.13%	153,645
21	IONS	Ionis Pharmaceuticals, Inc.	1.12%	130,838
22	VRTX	Vertex Pharmaceuticals Incorporated	1.12%	21,551
23	BIIB	Biogen Inc.	1.12%	58,717
24	BBIO	BridgeBio Pharma, Inc.	1.12%	158,113
25	ALNY	Alnylam Pharmaceuticals, Inc.	1.11%	17,842

Showing 25 of 144 holdings

Subscribe to see the full list

Upgrade Now

As of Sep 23, 2025